发明名称 COMPOSITIONS, USES AND METHODS FOR TREATMENT OF METABOLIC DISORDERS AND DISEASES
摘要 The invention relates to variants and fusions of fibroblast growth factor 19 (FGF19), variants and fusions of fibroblast growth factor 21 (FGF21), fusions of fibroblast growth factor 19 (FGF19) and/or fibroblast growth factor 21 (FGF21), and variants or fusions of fibroblast growth factor 19 (FGF19) and/or fibroblast growth factor 21 (FGF21) proteins and peptide sequences (and peptidomimetics), having one or more activities, such as glucose lowering activity, and methods for and uses in treatment of hyperglycemia and other disorders.
申请公布号 US2013023474(A1) 申请公布日期 2013.01.24
申请号 US201213538705 申请日期 2012.06.29
申请人 NGM BIOPHARMACEUTICALS, INC.;LING LEI;LINDHOUT DARRIN A. 发明人 LING LEI;LINDHOUT DARRIN A.
分类号 C07K14/50;A61K38/18;A61P3/00;A61P3/08;A61P3/10;A61P5/50;C12N1/19;C12N5/10;C12N15/12;C12N15/63;C12Q1/54;C12Q1/68;G01N33/566;G01N33/573 主分类号 C07K14/50
代理机构 代理人
主权项
地址